NEW YORK (GenomeWeb News) - DermTech, a molecular diagnostics company focused on skin diseases, said today that it is partnering with dermatology company Stiefel Laboratories to investigate the molecular causes of acne.
The companies have agreed to use DermTech’s Epidermal Genetic Information Retrieval, or EGIR, technology and its gene expression assays to study genes that are involved in causing acne. Stiefel hopes to use the data from this feasibility research to develop targeted acne treatments.
Under the agreement, DermTech will provide Stiefel with the EGIR skin-sampling technology, which uses adhesives that are applied to the patients' epidermis skin to collect RNA. DermTech said it will analyze the samples Stiefel collects using quantitative reverse transcriptase-PCR.
DermTech CEO George Schwartz said his company is “confident that we will be able to help confirm and identify the molecular causes of acne."